• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射兔载脂蛋白A-I可抑制喂饲胆固醇的兔的动脉粥样硬化进展。

Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits.

作者信息

Miyazaki A, Sakuma S, Morikawa W, Takiue T, Miake F, Terano T, Sakai M, Hakamata H, Sakamoto Y, Natio M

机构信息

Department of Biochemistry, Kumamoto University School of Medicine, Japan.

出版信息

Arterioscler Thromb Vasc Biol. 1995 Nov;15(11):1882-8. doi: 10.1161/01.atv.15.11.1882.

DOI:10.1161/01.atv.15.11.1882
PMID:7583568
Abstract

The effects of intravenous injection of purified rabbit apoA-I on the progression of aortic atherosclerosis in cholesterol-fed rabbits were examined. In experiment 1, 28 rabbits were equally divided into groups A and B and fed a 0.5% cholesterol diet for 90 days. For the last 30 days, group B received 40 mg apoA-I every week. The fatty streak lesions in group B (23.9 +/- 15.6%) were significantly suppressed compared with those in group A (46.0 +/- 24.9%) (P < .05). In experiment 2, 33 rabbits were divided into four groups (8 or 9 rabbits per group) and fed a 0.5% cholesterol diet. Group A was killed on day 105, while groups B, C, and D were maintained for an additional 60 days on a normal diet, during which time groups C and D received 1 mg apoA-I every other day or 40 mg apoA-I every week, respectively. The lesions in group C (70.2 +/- 15.4%) and group D (65.7 +/- 20.0%) were significantly suppressed compared with those in group B (86.2 +/- 13.7%) (P < .05) but were not reduced to the level of group A (50.0 +/- 22.9%). Although apparent regression was not observed under these conditions, the present study provided the first evidence for the antiatherogenic effect of homologous and apoA-I on the progression of atherosclerosis in cholesterol-fed rabbits.

摘要

研究了静脉注射纯化的兔载脂蛋白A-I对高胆固醇喂养兔主动脉粥样硬化进展的影响。在实验1中,28只兔被平均分为A组和B组,给予0.5%胆固醇饮食90天。在最后30天,B组每周接受40mg载脂蛋白A-I。与A组(46.0±24.9%)相比,B组的脂纹病变(23.9±15.6%)受到显著抑制(P<0.05)。在实验2中,33只兔被分为四组(每组8或9只兔),给予0.5%胆固醇饮食。A组在第105天处死,而B、C和D组在正常饮食下再维持60天,在此期间,C组和D组分别每隔一天接受1mg载脂蛋白A-I或每周接受40mg载脂蛋白A-I。与B组(86.2±13.7%)相比,C组(70.2±15.4%)和D组(65.7±20.0%)的病变受到显著抑制(P<0.05),但未降至A组(50.0±22.9%)的水平。尽管在这些条件下未观察到明显的消退,但本研究为同源载脂蛋白A-I对高胆固醇喂养兔动脉粥样硬化进展的抗动脉粥样硬化作用提供了首个证据。

相似文献

1
Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits.静脉注射兔载脂蛋白A-I可抑制喂饲胆固醇的兔的动脉粥样硬化进展。
Arterioscler Thromb Vasc Biol. 1995 Nov;15(11):1882-8. doi: 10.1161/01.atv.15.11.1882.
2
Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet.抗动脉粥样硬化的L-天冬氨酸和L-谷氨酸对喂饲高胆固醇饮食家兔血清脂蛋白胆固醇及载脂蛋白A-1和B的影响。
Nutr Metab Cardiovasc Dis. 2005 Jun;15(3):161-5. doi: 10.1016/j.numecd.2004.06.001.
3
Human apolipoprotein A-I exerts a prophylactic effect on high-fat diet-induced atherosclerosis via inflammation inhibition in a rabbit model.在兔模型中,人载脂蛋白A-I通过抑制炎症对高脂饮食诱导的动脉粥样硬化发挥预防作用。
Acta Biochim Biophys Sin (Shanghai). 2017 Feb 6;49(2):149-158. doi: 10.1093/abbs/gmw128.
4
Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits.
Circulation. 1996 Aug 15;94(4):713-7. doi: 10.1161/01.cir.94.4.713.
5
Does a HDL injection reduce the development of serum hyperlipidemia and progression of fatty streaks in cholesterol fed rabbits?高密度脂蛋白注射能否减少胆固醇喂养的兔子血清高脂血症的发生以及脂肪条纹的进展?
Prostaglandins Leukot Essent Fatty Acids. 1992 Oct;47(2):149-52. doi: 10.1016/0952-3278(92)90152-9.
6
The effect of the aged garlic extract, 'Kyolic', on the development of experimental atherosclerosis.aged蒜提取物“Kyolic”对实验性动脉粥样硬化发展的影响
Atherosclerosis. 1997 Jul 11;132(1):37-42. doi: 10.1016/s0021-9150(97)00078-6.
7
Combined effects of cholesterol reduction and apolipoprotein A-I expression on atherosclerosis in LDL receptor deficient mice.胆固醇降低和载脂蛋白A-I表达对低密度脂蛋白受体缺陷小鼠动脉粥样硬化的联合作用。
Atherosclerosis. 2002 Nov;165(1):15-22. doi: 10.1016/s0021-9150(02)00103-x.
8
Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits.
J Cardiovasc Pharmacol. 2001 Dec;38(6):947-55. doi: 10.1097/00005344-200112000-00017.
9
Exogenous supply of artificial lipoproteins does not decrease susceptibility to atherosclerosis in cholesterol-fed rabbits.外源性供应人工脂蛋白不会降低喂胆固醇的兔子患动脉粥样硬化的易感性。
Atherosclerosis. 1995 Mar;113(2):237-46. doi: 10.1016/0021-9150(94)05451-n.
10
Comparison of the antiatherogenic effects of isradipine and ramipril in cholesterol-fed rabbits: I. Effect on progression of atherosclerosis and endothelial dysfunction.伊拉地平与雷米普利对高胆固醇喂养家兔抗动脉粥样硬化作用的比较:I. 对动脉粥样硬化进展和内皮功能障碍的影响
J Cardiovasc Pharmacol. 1994 Mar;23(3):415-23.

引用本文的文献

1
Understanding the heterogeneity and dysfunction of HDL in chronic kidney disease: insights from recent reviews.理解慢性肾脏病中高密度脂蛋白的异质性和功能障碍:来自最新综述的见解。
BMC Nephrol. 2024 Nov 7;25(1):400. doi: 10.1186/s12882-024-03808-3.
2
In vivo anti-Salmonella properties of aqueous extract of prickly pear () cladode, hepatological and toxicological evaluation.仙人掌肉质茎水提取物的体内抗沙门氏菌特性、肝脏学及毒理学评价。
Food Sci Nutr. 2024 Mar 25;12(7):4761-4771. doi: 10.1002/fsn3.4123. eCollection 2024 Jul.
3
Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization.
针对脉络膜新生血管的抗血管内皮生长因子治疗策略在新生血管性年龄相关性黄斑变性中的应用。
Biomolecules. 2024 Feb 21;14(3):252. doi: 10.3390/biom14030252.
4
Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction.CSL112(载脂蛋白 A-I [人])预防心肌梗死患者主要不良心血管事件的生物学基础和作用机制。
Eur Heart J Cardiovasc Pharmacother. 2023 Jun 2;9(4):387-398. doi: 10.1093/ehjcvp/pvad014.
5
Effects of withdrawing an atherogenic diet on the atherosclerotic plaque in rabbits.撤除致动脉粥样化饮食对兔动脉粥样硬化斑块的影响。
Exp Ther Med. 2021 Jul;22(1):751. doi: 10.3892/etm.2021.10183. Epub 2021 May 12.
6
Butyric Acid Added Apically to Intestinal Caco-2 Cells Elevates Hepatic ApoA-I Transcription and Rescues Lower ApoA-I Expression in Inflamed HepG2 Cells Co-Cultured in the Basolateral Compartment.丁酸在顶端添加到肠道 Caco-2 细胞中可提高肝脏载脂蛋白 A-I 的转录,并挽救在基底外侧共培养的炎症 HepG2 细胞中较低的载脂蛋白 A-I 表达。
Biomolecules. 2021 Jan 7;11(1):71. doi: 10.3390/biom11010071.
7
Baseline white blood cell count-to-apolipoprotein A1 ratio as a novel predictor of long-term adverse outcomes in patients who underwent percutaneous coronary intervention: a retrospective cohort study.基线白细胞计数与载脂蛋白 A1 比值作为经皮冠状动脉介入治疗患者长期不良结局的新预测指标:一项回顾性队列研究。
Lipids Health Dis. 2020 Mar 16;19(1):43. doi: 10.1186/s12944-020-01206-w.
8
BMP1 5'UTR + 104 T/C gene variation: can be a predictive marker for serum HDL and apoprotein A1 levels in male patients with coronary heart disease.骨形态发生蛋白1(BMP1)5'非翻译区+104 T/C基因变异:可作为男性冠心病患者血清高密度脂蛋白及载脂蛋白A1水平的预测标志物。
Mol Biol Rep. 2018 Oct;45(5):1269-1276. doi: 10.1007/s11033-018-4283-8. Epub 2018 Jul 30.
9
Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early- Versus Late-Stage Atherosclerosis.载脂蛋白A-I在动脉粥样硬化早期和晚期的显著不同的抗动脉粥样硬化作用
JACC Basic Transl Sci. 2018 May 30;3(2):187-199. doi: 10.1016/j.jacbts.2017.11.004. eCollection 2018 Apr.
10
HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?HDL 模拟物输注与动脉粥样硬化消退:它是否仍被视为一种有效的治疗选择?
Curr Cardiol Rep. 2018 Jun 21;20(8):66. doi: 10.1007/s11886-018-1004-9.